Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | GLAXO FY26 | PFIZER FY26 | ABBOTINDIA FY26 | MEDANTA FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 45.82× | — | — | 61.95× | 61.95× -26% | |
| P/B | 18.66× | — | — | ◆ 8.70× | 8.70× +114% | |
| EV/EBITDA | ◆ 30.21× | — | — | 37.60× | 37.60× -20% | |
| Market Cap | ₹42,319 Cr | — | — | ₹34,473 Cr | ₹34,473 Cr +23% | |
| Growth | ||||||
| Revenue CAGR 3Y | 5.53% | 1.29% | 9.01% | ◆ 17.85% | 9.38% -41% | |
| Revenue CAGR 5Y | 3.62% | 2.39% | ◆ 9.96% | — | 6.18% -41% | |
| Net Income CAGR 3Y | 19.26% | 5.01% | 17.80% | ◆ 19.33% | 14.05% +37% | |
| Revenue YoY (latest Q) | 16.55% | — | — | ◆ 26.50% | 26.50% -38% | |
| Net Income YoY (latest Q) | ◆ 15.69% | — | — | -1.09% | -1.09% +1539% | |
| Profitability | ||||||
| EBITDA Margin | 34.26% | ◆ 35.88% | 27.31% | 20.84% | 28.01% +22% | |
| Net Income Margin | 27.11% | ◆ 28.67% | 22.40% | 12.56% | 21.21% +28% | |
| Return on Common Equity | ◆ 49.11% | 17.16% | 34.46% | 15.15% | 22.26% +121% | |
| Return on Capital Employed | ◆ 52.35% | 19.60% | 38.09% | 14.78% | 24.16% +117% | |
| Return on Assets | 24.57% | 14.69% | ◆ 24.99% | 10.38% | 16.69% +47% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | 0.00× | — | 0.30× | 0.15× -100% | |
| Interest Coverage | ◆ 455.22× | 89.28× | 72.67× | 8.80× | 56.92× +700% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹3,822 Cr | ₹2,520 Cr | ₹6,929 Cr | ₹4,410 Cr | ₹4,620 Cr -17% | |
| Net Income | ₹1,036 Cr | ₹722 Cr | ₹1,552 Cr | ₹554 Cr | ₹943 Cr +10% | |
| Total Assets | ₹4,324 Cr | ₹4,922 Cr | ₹6,502 Cr | ₹5,905 Cr | ₹5,776 Cr -25% | |
| EPS | ₹54.52 | — | — | ₹20.71 | ₹20.71 +163% | |
| Book Value per Share | ₹133.84 | — | — | ₹147.44 | ₹147.44 -9% | |